These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34847204)

  • 21. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
    Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
    Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
    Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
    Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics.
    Eijzenga W; Bleiker EM; Hahn DE; Kluijt I; Sidharta GN; Gundy C; Aaronson NK
    Psychooncology; 2014 Aug; 23(8):862-9. PubMed ID: 24443031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Evaluation of Predictive DNA Testing for Huntington's Disease in a Large German Center.
    Ibisler A; Ocklenburg S; Stemmler S; Arning L; Epplen JT; Saft C; Hoffjan S
    J Genet Couns; 2017 Oct; 26(5):1029-1040. PubMed ID: 28361381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family Adjustment to Hereditary Cancer Syndromes: A Systematic Review.
    Gomes P; Pietrabissa G; Silva ER; Silva J; Matos PM; Costa ME; Bertuzzi V; Silva E; Neves MC; Sales CMD
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A counselee-oriented perspective on risk communication in genetic counseling: explaining the inaccuracy of the counselees' risk perception shortly after BRCA1/2 test result disclosure.
    Vos J; Stiggelbout AM; Oosterwijk J; Gomez-Garcia E; Menko F; Collee JM; van Asperen CJ; Tibben A
    Genet Med; 2011 Sep; 13(9):800-11. PubMed ID: 21885922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome.
    Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ
    Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer Counseling of Low-Income Limited English Proficient Latina Women Using Medical Interpreters: Implications for Shared Decision-Making.
    Kamara D; Weil J; Youngblom J; Guerra C; Joseph G
    J Genet Couns; 2018 Feb; 27(1):155-168. PubMed ID: 28791541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
    de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
    Trials; 2014 Mar; 15():86. PubMed ID: 24649895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experiencing genetic counselling for hereditary cancers: the client's perspective.
    Mendes AF; Santos TA; Sousa L
    Eur J Cancer Care (Engl); 2011 Mar; 20(2):204-11. PubMed ID: 20597958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Counselees' Expressed Level of Understanding of the Risk Estimate and Surveillance Recommendation are Not Associated with Breast Cancer Surveillance Adherence.
    Albada A; van Dulmen S; Dijkstra H; Wieffer I; Witkamp A; Ausems MG
    J Genet Couns; 2016 Apr; 25(2):279-89. PubMed ID: 26321750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized experimental study to test the effects of discussing uncertainty during cancer genetic counseling: different strategies, different outcomes?
    Medendorp NM; Hillen MA; Visser LNC; Aalfs CM; Duijkers FAM; van Engelen K; Ausems MGEM; Verhoef S; Stiggelbout AM; Smets EMA
    Eur J Hum Genet; 2021 May; 29(5):789-799. PubMed ID: 33437034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of a follow-up study of genetic counseling.
    Abramovsky I; Godmilow L; Hirschhorn K; Smith H
    Clin Genet; 1980 Jan; 17(1):1-12. PubMed ID: 7389180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic counseling--the postcounseling period: I. Parents' perceptions of uncertainty.
    Lippman-Hand A; Fraser FC
    Am J Med Genet; 1979; 4(1):51-71. PubMed ID: 495654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of communicating uncertain test results in cancer genetic counseling: A systematic mixed studies review.
    Medendorp NM; van Maarschalkerweerd PEA; Murugesu L; Daams JG; Smets EMA; Hillen MA
    Patient Educ Couns; 2020 Sep; 103(9):1692-1708. PubMed ID: 32278626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Women's experiences with non-invasive prenatal testing in Switzerland: a qualitative analysis.
    Fang MT; Germani F; Spitale G; Wäscher S; Kunz L; Biller-Andorno N
    BMC Med Ethics; 2023 Oct; 24(1):85. PubMed ID: 37872496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
    Roshanai AH; Rosenquist R; Lampic C; Nordin K
    Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research Study.
    Sweet K; Hovick S; Sturm AC; Schmidlen T; Gordon E; Bernhardt B; Wawak L; Wernke K; McElroy J; Scheinfeldt L; Toland AE; Roberts JS; Christman M
    J Genet Couns; 2017 Aug; 26(4):738-751. PubMed ID: 27921197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk communication in completed series of breast cancer genetic counseling visits.
    Pieterse AH; van Dulmen S; van Dijk S; Bensing JM; Ausems MG
    Genet Med; 2006 Nov; 8(11):688-96. PubMed ID: 17108760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.